Betacin-N 0.1%+0.5% (Ophthalmic Solution)

5 ml drop: ৳ 35.00

Medicine Details

Category	Details
Generic	Betamethasone neomycin sulphate ee
Company	Ibn sina pharmaceuticals ltd

Eye: Inflammatory conditions (eg. uveitis, marginal keratitis, allergic conjunctivitis, blepharitis and episcleritis) where development of bacterial infection is likely
Ear: Otitis externa and other inflammatory conditions where bacterial infection is present or suspected
Nose: Inflammatory conditions where infection is present or suspected

Betamethasone is a corticosteroid which is effective in inflammatory dermatoses. It is also effective in less responsive conditions such as psoriasis
Neomycin sulfate is bactericidal against many bacteria which are commonly associated with skin infections

Drops: Eye: 1 drop instilled into the eye every one or two hours until control is achieved, when the frequency may be reduced
Drops: Ear: 2 or 3 drops instilled into the ear, every two or three hours until control is achieved, when the frequency can be reduced
Drops: Nose: 2 or 3 drops instilled into each nostril two or three times daily
Eye Ointment: It should be applied thinly and evenly to the conjunctival sac at night (If eye drops used during day) or 3-4 times daily (if ointment used alone)

Viral, fungal, tuberculous or purulent conditions
Use in the eye is contra-indicated if glaucoma is present or where herpetic keratitis (e.g. dendritic ulcer) is considered a possibility
Preparations containing neomycin should not be used for treating otitis externa when the ear drum is perforated, because of the risk of ototoxicity

Acute sensitization to neomycin is a rare event but can occur after topical application to the eye
Eye drops containing corticosteroids cause a serious rise in intra-ocular pressure in a small percentage of the population, including most of those with a family history of glaucoma
Thinning of the cornea leading to perforation has occurred with use of topical corticosteroids
Cataract is reported to have occurred after unduly prolonged treatment of eye conditions with topical corticosteroids

Pregnancy Category-Not Classified. FDA has not yet classified the drug into a specified pregnancy category
Topical administration of corticosteroid to pregnant animals can cause abnormalities of fetal development. The relevance of this finding to human beings has not been established; however, topical steroids should not be used extensively in pregnancy, i.e. in large amounts or for prolonged periods

Steroids should not be administered to 'red eyes' until a definitive diagnosis has been made
Ophthalmological treatment with steroid preparations should not be repeated or prolonged without regular review to exclude raised intra-ocular pressure or unsuspected infections
The unnecessary topical use of neomycin containing products should be avoided in order to minimize the occurrence of neomycin-resistant organisms (and organism cross-resistant to other aminoglycosides)